(Q38173993)

30 August 2017

title

Effect of chemoradiotherapy and neoadjuvant chemoradiotherapy in resectable pancreatic cancer: a systematic review and meta-analysis (English)

1 reference

30 August 2017

0 references

1 reference

1 reference

1 reference

C P Xu

1

1 reference

30 August 2017

X J Xue

2

1 reference

30 August 2017

N Liang

3

1 reference

30 August 2017

D G Xu

4

1 reference

30 August 2017

F J Liu

5

1 reference

30 August 2017

X S Yu

6

1 reference

30 August 2017

J D Zhang

7

1 reference

30 August 2017

language of work or name

1 reference

27 December 2013

1 reference

Journal of Cancer Research and Clinical Oncology

30 August 2017

published in

1 reference

30 August 2017

volume

140

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

549-559

1 reference

Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Current knowledge on pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Is adjuvant 5-FU-based chemoradiotherapy for resectable pancreatic adenocarcinoma beneficial? A meta-analysis of an unanswered question

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

A randomized phase 2 trial of neoadjuvant chemotherapy in resectable pancreatic cancer: gemcitabine alone versus gemcitabine combined with cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Does preoperative therapy optimize outcomes in patients with resectable pancreatic cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

A neoadjuvant strategy for pancreatic adenocarcinoma increases the likelihood of receiving all components of care: lessons from a single-institution database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant chemotherapy, with or without postoperative radiotherapy, for resectable advanced pancreatic adenocarcinoma: continue or stop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Surgical results after preoperative chemoradiation therapy for patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Open-label, multicenter, randomized phase III trial of adjuvant chemoradiation plus interferon Alfa-2b versus fluorouracil and folinic acid for patients with resected pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant 5-FU-based chemoradiotherapy for patients undergoing R-1/R-2 resections for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Neoadjuvant chemoradiation in patients with potentially resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Adjuvant Gemcitabine Alone Versus Gemcitabine-Based Chemoradiotherapy After Curative Resection for Pancreatic Cancer: A Randomized EORTC-40013-22012/FFCD-9203/GERCOR Phase II Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Impact of preoperative chemoradiotherapy on survival in patients with resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1572-4

Pancreatic carcinoma deemed unresectable at exploration may be resected for cure: an institutional experience.

21 January 2018

1 reference

12 December 2020

Pancreatic Resections after Chemoradiotherapy for Locally Advanced Ductal Adenocarcinoma: Analysis of Perioperative Outcome and Survival

1 reference

12 December 2020

Pre-operative chemoradiation for non-metastatic locally advanced rectal cancer

1 reference

12 December 2020

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial

1 reference

12 December 2020

Adjuvant therapy of resected adenocarcinoma of the pancreas

1 reference

12 December 2020

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

12 December 2020

Does neoadjuvant cisplatin-based chemotherapy improve the survival of patients with locally advanced bladder cancer: a meta-analysis of individual patient data from randomized clinical trials. Advanced bladder cancer overview collaboration.

1 reference

12 December 2020

Neoadjuvant chemotherapy and radiation for patients with locally unresectable pancreatic adenocarcinoma: feasibility, efficacy, and survival

1 reference

12 December 2020

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma

1 reference

12 December 2020

The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature

1 reference

12 December 2020

10.1007/S00432-013-1572-4

Identifiers

DOI

1 reference

30 August 2017

1 reference